
JYONG BIOTECH LTD
MENS · NASDAQ
Updated at 2026-10-15 12:00:45
- Today's High
- $2.11
- Today’s Low
- $1.97
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.06
- Previous Close
- $2.05
- Volume
- 32.83K
- Market Cap
- $152.17M
- P/E Ratio
- --
- EPS
- $-0.08
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- NO. 95, XINTAI 5TH ROAD, NEW TAIPEI CITY, TAIWAN, 221
- Country
- TW
- Listing Date
- 2025-06-17
- Fiscal Year End
- December
- Shares Outstanding
- 76.03M
- CIK
- --
- Website
- jyongbio.com
Jyong Biotech Ltd. (ticker: MENS) is a pioneering biotechnology firm focused on developing transformative therapeutic solutions for cancer and autoimmune diseases. Leveraging its expertise in genomics and molecular biology, the company has built a promising pipeline of innovative treatments supported by a formidable intellectual property portfolio. By establishing strategic partnerships within the biopharmaceutical sphere, Jyong Biotech is well-positioned to capitalize on emerging market opportunities, all while emphasizing scientific excellence and a patient-centered approach that enhances its standing in the healthcare innovation arena.
Financial Metrics
Revenue
2025-12-31
--
2025-09-30
--
2025-06-30
--
2024-12-31
--
Operating Expenses
2025-12-31
$1.79M
2025-09-30
$895.5
2025-06-30
$816K
2024-12-31
$552.5
Net Income
2025-12-31
-$3.41M
2025-09-30
-$1.7K
2025-06-30
-$1.25M
2024-12-31
-$846.5
Net Profit Margin
2025-12-31
--
2025-09-30
--
2025-06-30
--
2024-12-31
--
Earnings Per Share
2025-12-31
--
2025-09-30
--
2025-06-30
--
2024-12-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2025-12-31
-$1.79M
2025-09-30
-$865.5
2025-06-30
-$835K
2024-12-31
-$523.5
Effective Tax Rate
2025-12-31
--
2025-09-30
--
2025-06-30
--
2024-12-31
--
| Item | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | -- | -- | -- | -- |
| Operating Expenses | $1.79M | $895.5 | $816K | $552.5 |
| Net Income | -$3.41M | -$1.7K | -$1.25M | -$846.5 |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | -- | -- | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$1.79M | -$865.5 | -$835K | -$523.5 |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.